Capital Fund Management S.A. Genmab A/S Transaction History
Capital Fund Management S.A.
- $34.5 Billion
- Q2 2025
A detailed history of Capital Fund Management S.A. transactions in Genmab A/S stock. As of the latest transaction made, Capital Fund Management S.A. holds 226,584 shares of GMAB stock, worth $6.48 Million. This represents 0.01% of its overall portfolio holdings.
Number of Shares
226,584
Previous 107,523
110.73%
Holding current value
$6.48 Million
Previous $2.11 Million
122.38%
% of portfolio
0.01%
Previous 0.01%
Shares
6 transactions
Others Institutions Holding GMAB
# of Institutions
252Shares Held
65.2MCall Options Held
32.5KPut Options Held
55K-
Alliancebernstein L.P. New York, NY10.7MShares$305 Million0.08% of portfolio
-
Orbis Allan Gray LTD Hamilton, D07.92MShares$227 Million1.07% of portfolio
-
Black Rock Inc. New York, NY5.08MShares$145 Million0.0% of portfolio
-
Ken Griffin Citadel Advisors LLC | Chicago, Il3.57MShares$102 Million0.01% of portfolio
-
Arrowstreet Capital, Limited Partnership Boston, MA3.45MShares$98.8 Million0.05% of portfolio
About GENMAB A/S
- Ticker GMAB
- Exchange OTC
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 658,292,992
- Market Cap $18.8B
- Description
- Genmab A/S develops antibody therapeutics for the treatment of cancer and other diseases primarily in Denmark. The company markets DARZALEX, a human monoclonal antibody for the treatment of patients with multiple myeloma (MM); teprotumumab for the treatment of thyroid eye disease; ofatumurnab, a human monoclonal antibody to treat chronic lymphoc...